John Schembri

All filings by John Schembri on record concern Global Blood Therapeutics, Inc. We count 3 filings; the first trade dates from 17 August 2015 and the latest from 1 February 2016.

The open-market record is one-sided, with 2 purchases worth €30k and not one sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 1 share grant. In 2016 alone, the filings show 2 purchases and no sales.

On 3 February 2016 came the latest disclosure, a share grant in Global Blood Therapeutics, Inc. The last purchase on record was published on 7 January 2016, which is 3,959 days ago. Typically, a trade is published a median of 2 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.